<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134625</url>
  </required_header>
  <id_info>
    <org_study_id>1606-069-771</org_study_id>
    <nct_id>NCT03134625</nct_id>
  </id_info>
  <brief_title>Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation</brief_title>
  <official_title>Identification of Metabolite Biomarkers Related to Acute Rejection of Patients With Kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      The development of acute rejection can only be considered in cases with increasing serum
      creatinine in patients with kidney transplantation. However, the serum creatinine itself is
      not specific but also accurate for detection of acute rejection. So The specific biomarker is
      required for acute rejection of kidney transplant. In this study, the investigators will
      enroll 200 consecutive kidney transplant patients in Seoul National University Hospital and
      follow up. Serial collection of urine and serum will be done. Acute rejection specific urine
      metabolite will be found by LC MS/MS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2016</start_date>
  <completion_date type="Anticipated">July 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>biomarker for acute rejection in kidney transplantation</measure>
    <time_frame>1 year</time_frame>
    <description>urine metabolite which is specific for kidney transplant rejection</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>Rejection Acute Renal</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population includes low or moderate risk kidney transplantation. They should have
        triple immunosuppression.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Kidney transplant patients in Seoul National University Hospital

          -  Patients with triple maintenance immunosuppression including Tacrolimus, mycophenolate
             and steroid

        Exclusion Criteria:

          -  History of other organ transplantation

          -  ABOi and/or crossmatch(+) transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jongwon Ha, MD, PhD</last_name>
    <phone>+82-2-2072-2991</phone>
    <email>jwhamd@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jongwon Ha, MD, PhD</last_name>
      <phone>+82-2-2072-2991</phone>
      <email>jwhamd@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolomics</keyword>
  <keyword>biomarker</keyword>
  <keyword>acute rejection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

